Valuation Takeda Pharmaceutical Company Limited

Equities

4502

JP3463000004

Pharmaceuticals

Market Closed - Japan Exchange Other stock markets 02:30:00 2026-04-14 EDT			5-day change	1st Jan Change
5,604.00 ^JPY	-0.57%		-3.35%	+15.90%

05:46am	Pharma sector doubles down on AI amid hopes of slashing costs, timelines	RE
04-13	Spyre's inflammatory bowel drug shown to reduce disease activity in mid-stage study	RE

Company Valuation: Takeda Pharmaceutical Company Limited

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	6,229,971	5,423,454	6,762,204	6,564,378	6,749,675	8,903,826	-	-
Change	-	-12.95%	24.68%	-2.93%	2.82%	31.91%	-	-
Enterprise Value (EV) ¹	9,862,522	8,919,170	10,611,015	10,950,330	10,725,175	12,842,576	12,582,554	12,358,477
Change	-	-9.57%	18.97%	3.2%	-2.06%	19.74%	-2.02%	-1.78%
P/E ratio	16.6x	23.8x	21.3x	45.4x	64.6x	50.4x	34x	28.5x
PBR	1.2x	0.95x	1.06x	0.9x	1x	1.25x	1.26x	1.26x
PEG	-	-0.6x	0.5x	-0.8x	-2.5x	0.8x	0.7x	1.5x
Capitalization / Revenue	1.95x	1.52x	1.68x	1.54x	1.47x	1.97x	1.94x	1.92x
EV / Revenue	3.08x	2.5x	2.63x	2.57x	2.34x	2.83x	2.74x	2.66x
EV / EBITDA	9.23x	8.54x	9.19x	11.6x	9.71x	10.5x	10.5x	9.92x
EV / EBIT	19.4x	19.4x	21.6x	51.1x	31.3x	29.7x	24.4x	21.3x
EV / FCF	16x	8.92x	28.7x	43.4x	15.5x	15.2x	15.8x	15.6x
FCF Yield	6.26%	11.2%	3.49%	2.31%	6.43%	6.58%	6.33%	6.4%
Dividend per Share ²	180	180	180	188	196	200	203.4	207.4
Rate of return	4.52%	5.15%	4.14%	4.49%	4.44%	3.55%	3.61%	3.68%
EPS ²	240.7	147.1	204.3	92.09	68.36	111.8	165.8	197.9
Distribution rate	74.8%	122%	88.1%	204%	287%	179%	123%	105%
Net sales ¹	3,197,812	3,569,006	4,027,478	4,263,762	4,581,600	4,530,492	4,583,860	4,639,160
EBITDA ¹	1,068,940	1,043,995	1,154,905	942,077	1,103,982	1,227,417	1,201,220	1,245,488
EBIT ¹	509,269	460,844	490,505	214,100	342,600	432,429	515,251	580,539
Net income ¹	376,005	230,059	317,017	144,067	107,900	173,535	258,727	305,376
Net Debt ¹	3,632,551	3,495,716	3,848,811	4,385,952	3,975,500	3,938,750	3,678,728	3,454,651
Reference price ²	3,985.00	3,498.00	4,350.00	4,184.00	4,413.00	5,636.00	5,636.00	5,636.00
Nbr of stocks (in thousands)	1,563,355	1,550,444	1,554,530	1,568,924	1,529,498	1,579,813	-	-
Announcement Date	5/11/21	5/11/22	5/11/23	5/9/24	5/8/25	-	-	-

¹JPY in Million²JPY

Estimates

P/E ratio, Detailed evolution

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
TAKEDA PHARMACEUTICAL COMPANY LIMITED	50.42x	2.83x	10.46x	3.55%	55.74B
ELI LILLY AND COMPANY	27.39x	10.36x	20.75x	0.73%	832B
JOHNSON & JOHNSON	25.22x	5.87x	15.95x	2.22%	573B
ABBVIE INC.	23.23x	6.22x	12.63x	3.36%	365B
ASTRAZENECA PLC	25.43x	5.25x	14.83x	1.65%	313B
MERCK & CO., INC.	28.43x	4.94x	15.35x	2.81%	297B
NOVARTIS AG	21.18x	5.7x	13.8x	2.88%	292B
AMGEN INC.	23.4x	6.05x	10.77x	2.87%	189B
GILEAD SCIENCES, INC.	19.14x	5.87x	10.78x	2.34%	173B
Average	27.09x	5.90x	13.93x	2.49%	343.21B
Weighted average by Cap.	25.52x	6.91x	15.77x	2.08%